Mixing meds

25 Sep 2006 By John Foley

The race to consolidate is clearly on. The Belgian group is the third midsized European drugs group to buy a rival in the past week. What has unblocked the dam? It s that the sellers have all dropped their prices, perhaps because they are scared of being left on the shelf.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)